12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Deals

Raptor, Seattle Children's Research Institute deal

The institute granted Raptor exclusive, worldwide rights to IP related to cysteamine and related compounds for the potential treatment...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >